Affiliations

NYBA

Australia Biotech

BioMelbourne

Lab To Wall Street

Of Counsel To Firm

Brooklyn native John Balestriere is an experienced trial attorney, investigator, and consultant who has built a distinguished career handling criminal and civil cases at the trial and appellate levels in state and federal courts throughout New York and conducting a wide variety of investigations. He is a graduate of Monsignor Farrell High School, Columbia College, and the Yale Law School.

Mr. Balestriere represents individual and company clients in criminal and regulatory matters and all stages of complex civil litigation, including depositions trials, and appeals in federal and state courts. He also represents clients in intense negotiations and arbitrations, and directs internal investigations into alleged misconduct at companies, institutions, and government entities.

Mr. Balestriere has seven years of law enforcement experience in both Eliot Spitzer's State Attorney General's Office and Robert Morgenthau's Manhattan District Attorney's Office. He first worked for Mr. Morgenthau after college as an analyst in the Rackets Bureau, assisting attorneys in investigations into judicial and political corruption, Cosa Nostra organized crime groups, major narcotics distribution gangs, and identity theft. After law school, Mr. Balestriere served in that same office as an Assistant District Attorney in the Trial Division, trying a significant number of cases to juries, and handling cases from the lowest level misdemeanors to the highest level felonies. While there he also specialized in Domestic Violence and Sex Crimes prosecution, and conducted investigations into bribery of government officials, organized employee theft schemes, and credit card fraud.

Mr. Balestriere was recruited from the District Attorney's Office to work in a newly created investigative unit in the New York State Attorney General's Office. In that specialized unit he directed teams of former police detective investigators, financial auditors, and investigative analysts into long term investigations of organized crime, insurance fraud, human trafficking, and large identity theft rings. Such investigations led to the arrest and indictment of dozens of individuals, including entire gangs who, working with doctors, lawyers, and other professionals, perpetrated large auto insurance fraud schemes throughout the New York City area. Mr. Balestriere also devised a unit-wide intelligence system that allowed varied investigators and attorneys to pool their resources and more intelligently conduct investigations into a variety of frauds.

After work as a criminal prosecutor and investigator, Mr. Balestriere joined a small class action firm where he prosecuted securities, antitrust, and consumer fraud cases against the largest banks and public companies in the world. His adversaries were lawyers from the top corporate firms, and he often litigated before some of the most demanding judges in the nation in Manhattan federal court. Mr. Balestriere worked alongside the most experienced attorneys of the plaintiffs' bar in litigating complex civil matters in federal and state trial and appellate courts, including managing complicated discovery which included taking and defending depositions. In a series of cases against investment banks and their analysts, Mr. Balestriere wrote legal briefs that became the basis for newly created law in the area of securities fraud.

Mr. Balestriere has been quoted in media in the United States and abroad, from The New York Times to the Birmingham Post-Herald to RAI television, the official broadcasting channel of the Italian government. He has commented on a range of topics from ongoing criminal trials, to pending civil actions, to recently passed legislation, to the emerging use of the class action device in foreign countries.

Mr. Balestriere is admitted to practice law in New York State, as well as to the bars of the United States Supreme Court, the United States Court of International Trade, and the Southern and Eastern District Courts of New York.

For further information on Mr. Balestriere's practice, please visit: www.balestriere.net

See bio of Roger O'Sullivan >

See bio of Eric N. Cohen >
See bio of Seth Kaufman >

  May 28th, 2009:
Arana Therapeutics Board Changes

May 6th, 2009:
Circadian Scientific Advisory Board Chairman, Professor Kari Alitalo, Wins Prestigious Award for Biomedical Research

May 5th, 2009:
Living Cell Technologies Reports Insulin Independence in Two Patients Following Recent Implants of DIABECELL® in Diabetes Clinical Trial

November 3rd:
FDA Accepts Arana's Anti-inflammatory IND

September 4th:
Cytopia Commences Second Phase II Study in Brain Cancer

September 4th:
Pharmaxis Announces Second Pivotal Phase 3 Trial in Cystic Fibrosis Begins

August 6th:
Xenome Strengthens Board with Two New Appointments

August 6th:
Ciba Elects to Cease Industrial Product Evaluations

June 24th:
New Pharmaxis Board Appointment

April 29th:
Benitec secures further rights to HIV Therapeutic

more industry news >
 


osullivanpllc.com  

Disclaimer